Suppr
超能文献

Physiology. COX-2 inhibitors and cardiovascular risk.

作者信息

Cannon Christopher P, Cannon Paul J

机构信息

Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

出版信息

Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398.

DOI:10.1126/science.1224398

PMID:22700906

Abstract

摘要

相似文献

Physiology. COX-2 inhibitors and cardiovascular risk.

Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398.

COX-2 inhibitors and cardiovascular risk.

J Cardiovasc Pharmacol. 2007 Nov;50(5):470-9. doi: 10.1097/FJC.0b013e318157f72d.

Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.

Gastroenterology. 2006 Jan;130(1):55-64. doi: 10.1053/j.gastro.2005.10.002.

[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].

Yao Xue Xue Bao. 2005 Nov;40(11):967-9.

The pharmacology of selective inhibition of COX-2.

Thromb Haemost. 2006 Oct;96(4):393-400.

Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events.

FASEB J. 2006 Dec;20(14):2468-75. doi: 10.1096/fj.06-6615com.

COX-2 inhibitors and the thrombotic risk.

Thromb Haemost. 2006 Oct;96(4):391-2.

Pivotal role of protein kinase Cdelta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1169-76. doi: 10.1161/ATVBAHA.110.216044. Epub 2011 Feb 10.

Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.

Cardiol Clin. 2008 Nov;26(4):589-601. doi: 10.1016/j.ccl.2008.06.004.

The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.

J Cardiovasc Pharmacol Ther. 2007 Jun;12(2):98-111. doi: 10.1177/1074248407301172.

引用本文的文献

Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.

Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1330-1345. doi: 10.1161/ATVBAHA.123.318964. Epub 2024 Apr 11.

Cardiovascular Safety of Celecoxib after Cardiac Surgery with Cardiopulmonary Bypass: A Retrospective Cohort Study.

Ann Clin Epidemiol. 2021 Oct 1;3(4):101-108. doi: 10.37737/ace.3.4_101. eCollection 2021.

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response.

iScience. 2023 Aug 16;26(9):107631. doi: 10.1016/j.isci.2023.107631. eCollection 2023 Sep 15.

Synthesis, Biological, Spectroscopic and Computational Investigations of Novel -Acylhydrazone Derivatives of Pyrrolo[3,4-]pyridazinone as Dual COX/LOX Inhibitors.

Molecules. 2023 Jul 18;28(14):5479. doi: 10.3390/molecules28145479.

Can Nonsteroidal Anti-Inflammatory Drugs Lead to First-Time Heart Failure in Patients with Diabetes Mellitus Type-2: Is There a Link?

Pharmacology. 2023;108(5):492-494. doi: 10.1159/000531604. Epub 2023 Jul 27.

Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis.

J Med Chem. 2023 Jul 27;66(14):9313-9324. doi: 10.1021/acs.jmedchem.3c00655. Epub 2023 Jul 17.

Design, Synthesis, Biological Evaluation, and Molecular Docking Study of 4,6-Dimethyl-5-aryl/alkyl-2-[2-hydroxy-3-(4-substituted-1-piperazinyl)propyl]pyrrolo[3,4-]pyrrole-1,3(2,5)-diones as Anti-Inflammatory Agents with Dual Inhibition of COX and LOX.

Pharmaceuticals (Basel). 2023 May 29;16(6):804. doi: 10.3390/ph16060804.

Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine.

Int J Mol Sci. 2023 Apr 26;24(9):7897. doi: 10.3390/ijms24097897.

Interactions of -Mannich Bases of Pyrrolo[3,4-]pyrrole with Artificial Models of Cell Membranes and Plasma Proteins, Evaluation of Anti-Inflammatory and Antioxidant Activity.

Membranes (Basel). 2023 Mar 17;13(3):349. doi: 10.3390/membranes13030349.

Temporal Expression of Neuroinflammatory and Oxidative Stress Markers and Prostaglandin E2 Receptor EP2 Antagonist Effect in a Rat Model of Epileptogenesis.

ACS Pharmacol Transl Sci. 2022 Dec 8;6(1):128-138. doi: 10.1021/acsptsci.2c00189. eCollection 2023 Jan 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Physiology. COX-2 inhibitors and cardiovascular risk.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译